Product Information
JUNEL FE 24 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1748 per EA under NDC 00093532862. Its NADAC has been published 582 times since Aug 12, 2015.
FDA first approved this application on Dec 1, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093532862
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA090938FDA Approved
12/1/2014
TE Code
AB
On Market Since
6/8/2015
Price Statistics
The NADAC for JUNEL FE 24 TABLET has been published 582 times since Aug 12, 2015, and over the history we have for it it has declined 91.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1748 per EA |
|---|---|
| All-time high | $2.3292 (Sep 14, 2016) |
| All-time low | $0.1748 (Sep 23, 2026) |
| 52-week high | $0.2213 |
| 52-week low | $0.1748 |
| Median price | $0.9113 |
| Average price | $0.8934 |
| Largest weekly change | +33.9% (Aug 21, 2024) |
| Weeks tracked | 582 |
| Tracking since | Aug 12, 2015 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of JUNEL FE 24 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for JUNEL FE 24 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1748 per EA (NDC 00093532862), effective Sep 30, 2026.
How has the price of JUNEL FE 24 TABLET changed over time?
Over the history we have for it, the NADAC for JUNEL FE 24 TABLET has declined 91.8%. It has been tracked across 582 weekly CMS publications since Aug 12, 2015.
What are the highest and lowest recorded NADAC prices for JUNEL FE 24 TABLET?
Since Aug 12, 2015, the NADAC for JUNEL FE 24 TABLET has ranged from a low of $0.1748 (Sep 23, 2026) to a high of $2.3292 (Sep 14, 2016), with a median of $0.9113 per EA.
Are there cheaper alternatives to JUNEL FE 24 TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TARINA FE 1-20 EQ TABLET, is $0.1287 per EA — about 26% below JUNEL FE 24 TABLET.
Who manufactures JUNEL FE 24 TABLET?
JUNEL FE 24 TABLET (NDC 00093532862) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.